These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1233 related items for PubMed ID: 9058126

  • 1. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C, Backmerhoff F, Schumacher B, Niederau C.
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [Abstract] [Full Text] [Related]

  • 2. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 3. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH, Vogl D, Gross V, Lang B, Schölmerich J, Andus T.
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [Abstract] [Full Text] [Related]

  • 4. [Serum acute phase proteins for determining disease activity of ulcerative colitis and Crohn disease].
    Vucelić B, Milicić D, Krznarić Z, Korać B, Sentić M, Hadzić N, Stavljenić A, Cvorisćec D.
    Acta Med Austriaca; 1991 Nov; 18(4):100-5. PubMed ID: 1722373
    [Abstract] [Full Text] [Related]

  • 5. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ, Sáez-Royuela F, Yuguero del Moral L, Martín Lorente JL, Ojeda Giménez C.
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [Abstract] [Full Text] [Related]

  • 6. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
    Martínez-Borra J, López-Larrea C, González S, Fuentes D, Dieguez A, Deschamps EM, Pérez-Pariente JM, López-Vázquez A, de Francisco R, Rodrigo L.
    Am J Gastroenterol; 2002 Sep; 97(9):2350-6. PubMed ID: 12358255
    [Abstract] [Full Text] [Related]

  • 7. Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease.
    Riché F, Dosquet C, Panis Y, Valleur P, Laisné MJ, Briard C, Wautier JL.
    J Am Coll Surg; 1995 Jun; 180(6):718-24. PubMed ID: 7773486
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
    Schinzari F, Armuzzi A, De Pascalis B, Mores N, Tesauro M, Melina D, Cardillo C.
    Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
    [Abstract] [Full Text] [Related]

  • 9. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C, Wiebecke B, Loeschke K.
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [Abstract] [Full Text] [Related]

  • 10. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
    Vucelić B, Krznarić Z, Sentić M, Milicić D, Korać B, Cvorisćec D, Stavljenić A.
    Lijec Vjesn; 1990 Jun; 112(9-10):281-4. PubMed ID: 2093781
    [Abstract] [Full Text] [Related]

  • 11. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C, Boirivant M, De Toma G, Cerci S, Subioli S, Scuro L, Ferrari P, Pallone F.
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [Abstract] [Full Text] [Related]

  • 12. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
    Szkaradkiewicz A, Marciniak R, Chudzicka-Strugała I, Wasilewska A, Drews M, Majewski P, Karpiński T, Zwoździak B.
    Arch Immunol Ther Exp (Warsz); 2009 Jun; 57(4):291-4. PubMed ID: 19578817
    [Abstract] [Full Text] [Related]

  • 13. [Levels of cytokines in mucosal biopsies of Crohn's colitis. Physiopatological observations].
    Marongiu L, Scintu F, Melis MV, Pisano M, Zorcolo L, Capra F, Casula G.
    Minerva Chir; 2002 Feb; 57(1):35-40. PubMed ID: 11832856
    [Abstract] [Full Text] [Related]

  • 14. Serum amyloid A: a novel serum marker for the detection of systemic inflammatory response in cystitis.
    Lannergard A, Friman G, Larsson A.
    J Urol; 2003 Sep; 170(3):804-6. PubMed ID: 12913703
    [Abstract] [Full Text] [Related]

  • 15. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
    Liang M, Wang L, Hou FF, Liu J, Liu ZQ, Tian JW.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
    [Abstract] [Full Text] [Related]

  • 16. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T, Lemmers A, Louis E, Nicaise C, Quertinmont E, Belaiche J, Roland S, Van Gossum A, Devière J, Franchimont D.
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [Abstract] [Full Text] [Related]

  • 17. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
    Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA.
    Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
    [Abstract] [Full Text] [Related]

  • 18. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [Abstract] [Full Text] [Related]

  • 19. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1143-52. PubMed ID: 15569117
    [Abstract] [Full Text] [Related]

  • 20. Intraperitoneal cytokine productions and their relationship to peritoneal sepsis and systemic inflammatory markers in patients with inflammatory bowel disease.
    Yamamoto T, Umegae S, Kitagawa T, Matsumoto K.
    Dis Colon Rectum; 2005 May 15; 48(5):1005-15. PubMed ID: 15785898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.